Study Stopped
The study site preferred to conduct a non-randomized QI project
Adolescent PCIP Randomized Feasibility Trial
APCIP
Adolescent BREATHE Primary Care Intervention for PTSD (PCIP) Randomized Feasibility Trial
1 other identifier
interventional
N/A
1 country
1
Brief Summary
There are three research questions: (1) whether the Primary Care Intervention for PTSD (PCIP) improves health outcomes; (2) whether and how the PCIP can be sustainably delivered via telehealth; and (3) how PCIP compares to treatment as usual (TAU) participants. The mixed methods randomized feasibility trial of the protocol will be measured by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance) (n=44 patients and their care givers). We will collect data on patient, caregiver, and clinic staff participation, retention, and satisfaction (Reach and Adoption), change in hypothesized treatment mechanisms and symptoms (Effectiveness), and facilitators and barriers to intervention delivery and fidelity (Implementation). We will,
- 1.Assess the reach and adoption of the protocol by analyzing quantitative data on patient and clinic staff participation, retention, and satisfaction;
- 2.Explore the effectiveness of the protocol through medical record review, quantitative assessments at baseline and post-treatment, and semi-structured qualitative interviews at baseline and post-treatment to:
- 3.Evaluate the implementation of the screening and intervention protocol with post-intervention semi-structured qualitative interviews to assess facilitators and barriers to intervention delivery, quantitative fidelity scales, observation of screening, and review of intervention audio recordings to assess fidelity to the protocol and intervention process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2021
CompletedFirst Posted
Study publicly available on registry
October 22, 2021
CompletedStudy Start
First participant enrolled
January 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedFebruary 27, 2026
February 1, 2026
4 years
September 29, 2021
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in PTSD Knowledge
Changes in levels of PTSD Knowledge measured by the PTSD Knowledge Test (0-14, higher scores indicating more PTSD knowledge)
Day 0 baseline, 10 months
Change in Trauma-Related Cognitions
Changes in post-traumatic cognitions measured by the Post-Traumatic Cognitions Inventory (1-7, Higher scores indicating more post traumatic cognitions)
Day 0 baseline, 10 months
Change in Self-Reported Arousal
Changes in PTSD related arousal levels measured by the Composite Autonomic Symptom Score (COMPASS-31; 0-100 total, Higher scores indicating higher arousal)
Day 0 baseline, 10 months
Change in Stress Management Skill Use
Changes in PTSD related arousal levels measured Measure of Adolescent Coping Strategies (MACS; Total 0-102, higher scores indicate higher use of specified coping), and use of the breathing retraining techniques as measured by self-reports during in-session review.
Day 0 baseline, 10 months
Intervention Implementation and Acceptability
Qualitative interviews will include questions regarding acceptability of treatment including treatment via telehealth. Additionally, data will be collected regarding participant completion of therapy, no show rates, barriers to treatment, and attendance. Additionally, study therapists will complete qualitative and quantitative measures regarding intervention delivery feasibility and study protocols.
Day 0 baseline, 10 months
Secondary Outcomes (10)
Change in PTSD Symptoms
Day 0 baseline, 10 months
Change in Trauma Symptoms
Day 0 baseline, 10 months
Change in Adverse Childhood Experiences
Day 0 baseline, 10 months
Change in Depression Symptoms
Day 0 baseline, 10 months
Change in Depression Symptoms
Day 0 baseline, 10 months
- +5 more secondary outcomes
Study Arms (2)
BREATHE Primary Care Intervention for PTSD (PCIP)
EXPERIMENTALBREATHE PCIP is a treatment for Post-Traumatic Stress Disorder (PTSD) symptoms for use with individuals who have a diagnosis of PTSD or "probable PTSD." The treatment will be considered delivered when patients have learned and practiced breathing retraining and have discussed the symptoms of PTSD (Sessions 1 through 3).
Treatment As Usual
ACTIVE COMPARATORReceive standard care treatment and provided information on free or low cost mental health care referrals in the Los Angeles Area.
Interventions
This program is adapted from the "B.R.E.A.T.H.E. - Brief Relaxation, Education and Trauma Healing: A Brief Intervention for Persons with PTSD and Co- Occurring Serious Mental Health Conditions. Treatment Program Manual and Patient Handouts (Version 3) by Kim T. Mueser, Rachael Fite, Stanley D. Rosenberg, and Jennifer D. Gottlieb.
Receive standard care treatment and are provided information on free or low cost mental health care referrals in the Los Angeles Area.
Eligibility Criteria
You may qualify if:
- Patient referred to the SHARK Program
- Patients must be at least 12 years old
- Screened for probable PTSD on UCLA RI, or at provider discretion of clinical relevancy.
- If patient is under 18 years old, the patient's legal guardian is able and willing to provide informed consent for the patient to participate in the study;
- Patient is able to complete study activities in English.
You may not qualify if:
- Suicidal ideation with a plan within the last two weeks or a suicide attempt within the past 30 days;
- Inability to provide informed consent or assent, and/or complete procedures in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California Los Angeles
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lauren C Ng, PhD
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 29, 2021
First Posted
October 22, 2021
Study Start
January 3, 2022
Primary Completion
December 20, 2025
Study Completion
December 20, 2025
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share